ArticleCancers2019

Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy.

Richard S Laschanzky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.